JNJ

2024Q1BMO

Johnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-04-16 · Fiscal end 2024-03-31 · Features as of 2024-04-15

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.65
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2024-04-15

Run-up

Close—
Ret 5d-2.6%
Ret 10d-6.5%
Ret 20d-6.7%
Ret 30d-9.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.71Beat
Estimated EPS2.65
Actual revenue
21.4B
Surprise %+2.3%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction-0.4%
Implied vs actual

Implied 1.7%Actual 1.7%

Gap reaction-1.7%
Day result-2.1%
Next-day upNo
Realized / IV1.01×

Post tape

Post 5d+3.5%
Post 10d+0.1%
Post volume12.8M
Vol ×10d1.82×
Vol ×20d1.87×
Post range2.0%